Stay updated on BA3021 in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the BA3021 in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BA3021 in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Study status updated to Completed with primary completion and study completion dates listed as 2025-09-22. Enrollment is shown as 42 across seven locations in the United States.
    Difference
    0.4%
    Check dated 2025-10-28T02:39:08.000Z thumbnail image
  3. Check
    30 days ago
    Change Detected
    Summary
    The page now includes a funding-status notice and a current operating status link, and updates the revision to v3.2.0 while removing the older Last Update Posted label and v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T16:00:00.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    New Phase 2 Ozuriftamab Vedotin study added with current dates and 7 locations; older recruitment details, contacts, and Oregon-specific listings removed. Overall, page content now centers on the updated Phase 2 trial information.
    Difference
    8%
    Check dated 2025-09-29T09:54:42.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.2%
    Check dated 2025-09-15T00:21:38.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:46:44.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its content to include specific resources related to head and neck cancer, including new medical terms and treatments, while removing some previous location details and disease attributes.
    Difference
    7%
    Check dated 2025-08-31T13:00:34.000Z thumbnail image

Stay in the know with updates to BA3021 in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BA3021 in Head and Neck Cancer Clinical Trial page.